• Strong Year-Over-Year Growth across Key Metrics Underscores Company’s Position as a Premier Global Technology Platform for Entertainment and Events
• Global Box Office of
  
  $247.7 Million
  
  (+128.1% YoY) Driven by “Top Gun: Maverick”, “Doctor Strange in the Multiverse of Madness” and “Jurassic World Dominion” as Dramatic Surge in Moviegoing Expands across Demographics and Regions
• Company Repurchased
  
  2.7M
  
  Shares in Second Quarter;
  
  6.4M
  
  Since 2020, or 11% of total shares outstanding
• IMAX Expects to Release 15 Local Language Titles across 50 Global Markets in the Third Quarter
• IMAX China Network 91% Operational — up from 65% on
  
  April 26
  

NEW YORK


,


July 28, 2022


/PRNewswire/ — IMAX Corporation (NYSE: IMAX) today reported solid financial results for the Second Quarter of 2022 demonstrating its leadership position in the global resurgence of moviegoing. Total Gross Box Office increased to

$247.7 million

from

$108.6 million

in the second quarter of 2021. Revenue increased to

$74.0 million

from

$51.0 million

and Gross Margin increased to

$44.0 million

from

$25.6 million

in the year-ago period.

For the Second Quarter of 2022, the net loss attributable to common shareholders was

($2.9) million

, or

($0.05)

per share, compared to

($9.2) million

, or

($0.16)

per share, last year and Adjusted Net Income attributable to common shareholders

⁽¹⁾

was

$3.9 million

, or

$0.07

per share, compared to an Adjusted Net Loss attributable to common shareholders

⁽¹⁾

of

($7.0) million

, or

($0.12)

per share, last year. The Company’s Second Quarter 2022 Adjusted Net Income attributable to common shareholders

⁽¹⁾

includes a

$3.2 million

, or

$0.06

per share impairment of a film investment, due in part to Covid related lockdowns and depressed box office levels in

China

. The Company’s Second Quarter 2022 Adjusted Net Income attributable to common shareholders

⁽¹⁾

also includes a

$5.1 million

, or

$0.09

per share, valuation allowance against its deferred tax assets.

Adjusted EBITDA per Credit Facility

⁽¹⁾

of

$25.4 million

was up from

$8.7 million

in the second quarter of 2021. On a trailing 12-month basis, Adjusted EBITDA per Credit Facility

⁽¹⁾

was

$97.3 million

as of June 30th.

“IMAX is playing a leading role in the global resurgence in moviegoing, as demonstrated by our strong financial results, global box office growth, and market share gains we delivered in the second quarter. In fact, our second quarter results in

North America

were on par with our record-breaking 2019, as consumers continue to seek out IMAX as a destination for fandom,” said

Richard L. Gelfond

, CEO of IMAX Corporation.

(1)     Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the Non-GAAP Financial Measures used herein, as well as reconciliations to the most comparable GAAP amounts.

“With three consecutive

$25 million

-plus global openings for the first time in its history, IMAX continued to affirm its position as a critical launch platform for major entertainment franchises. As the year progresses with key titles such as

Brad Pitt’s

‘Bullet Train’, Dwayne ‘The Rock’ Johnson’s ‘Black Adam’, ‘Black Panther: Wakanda Forever’ and ‘Avatar: The Way of Water’ and a remarkable offering of franchise tentpoles through 2023, we are focused on driving future growth for the Company across our global network, content portfolio, and technology platform.”

“We are encouraged by recent activity to strengthen key partnerships with global exhibitors, including agreements for new theatres and installations across

Asia

,

Europe

, the

Middle East

, and

North America

. We also continue to enhance and diversify our content portfolio, with

Hollywood

blockbusters, more of which feature IMAX DNA; local language blockbusters across a growing international footprint; IMAX documentaries; and exclusive live events and experiences from a growing roster of new partners.”

_______________

(1)     Non-GAAP Financial Measure. See the discussion at the end of this earnings release for a description of the non-GAAP financial measures used herein, as well as reconciliations to the most comparable GAAP amounts.

_______________

(1)     Please refer to the Company’s Form 10-Q for the period ended

June 30, 2022

for additional segment information.

IMAX Technology Network

• IMAX Technology Network revenues increased 134% to
  
  $46.1 million
  
  in the second quarter of 2022, compared to
  
  $19.7 million
  
  in the prior-year period. The strength of key titles such as “Doctor Strange in the Multiverse of Madness”, “Top Gun: Maverick” and “Jurassic World Dominion” drove the increase in gross box office and revenue.
• Gross margin for the IMAX Technology Network increased to
  
  $30.9 million
  
  in the second quarter of 2022, compared to
  
  $8.7 million
  
  in the prior year period as improved box office performance drove higher revenue.

IMAX Technology Sales and Maintenance

• IMAX Technology Sales and Maintenance revenues decreased 15% to
  
  $24.3 million
  
  in the second quarter of 2022, compared with
  
  $28.7 million
  
  in the prior year period. The decrease in revenue was driven by seven fewer installations, including upgrades, compared to the second quarter 2021, partially offset by increased maintenance revenues.
• Total gross margin for IMAX Technology Sales and Maintenance decreased 20% to
  
  $12.8 million
  
  in the second quarter of 2022 compared to
  
  $16.1 million
  
  in the prior year period. The decrease in gross margin was the result of fewer system installations completed, partially offset by increased maintenance margin.

Cash Balances and Outstanding Debt

Total cash and cash equivalents as of

June 30, 2022

were

$110.1 million

. Total debt, excluding deferred financing fees, was

$230.0 million

as of

June 30, 2022

.

Share Count and Capital Return

The weighted average basic and diluted shares outstanding at the end of the second quarter of 2022 was 57.3 million and 57.9 million, respectively, compared to 59.4 million in the second quarter of 2021. During the second quarter of 2022, the Company repurchased 2,702,548 shares at an average price of

$15.92

for a total of

$43.0 million

and IMAX China did not repurchase any shares. As of

June 30, 2022

, a total of

$26.2 million

remains available under the Company’s outstanding share repurchase authorization.

Supplemental Materials

For more information about the Company’s results, please refer to the IMAX Investor Relations website located at


investors.imax.com

.

Investor Relations Website and Social Media

On a weekly basis, the Company posts quarter-to-date box office results on the IMAX Investor Relations website located at


investors.imax.com


. The Company expects to provide such updates on Friday of each week, although the Company may change this timing without notice. Results will be displayed with a one-week lag.

The Company may post additional information on the Company’s corporate and Investor Relations website which may be material to investors. Accordingly, investors, media and others interested in the Company should monitor the Company’s website in addition to the Company’s press releases, SEC filings and public conference calls and webcasts, for additional information about the Company.

Conference Call

The Company will host a conference call today at

4:45 PM ET

to discuss its second quarter 2022 financial results. This call is being webcast by PGI and can be accessed at

investors.imax.com

. To access the call via telephone, interested parties in the US and

Canada

should dial (888) 220-8451 approximately 5 to 10 minutes before the call begins. Other international callers should dial (647) 484-0475. The conference ID for the call is 7250150. A replay of the call will be available via webcast at

investors.imax.com

or via telephone by dialing (888) 203-1112 (US and

Canada

), or (647) 436-0148 (international). The Conference ID for the telephone replay is 7250150.

About IMAX Corporation

IMAX, an innovator in entertainment technology, combines proprietary software, architecture, and equipment to create experiences that take you beyond the edge of your seat to a world you’ve never imagined. Top filmmakers and studios are utilizing IMAX theaters to connect with audiences in extraordinary ways, and, as such, IMAX’s network is among the most important and successful theatrical distribution platforms for major event films around the globe.

IMAX is headquartered in

New York

,

Toronto

, and

Los Angeles

, with additional offices in

London

,

Dublin

,

Tokyo

, and

Shanghai

. As of

June 30, 2022

, there were 1,694 IMAX theater systems (1,610 commercial multiplexes, 12 commercial destinations, 72 institutional) operating in 87 countries and territories. Shares of IMAX China Holding, Inc., a subsidiary of IMAX Corporation, trade on the Hong Kong Stock Exchange under the stock code “1970.”

IMAX

^®

, IMAX

^®

Dome, IMAX

^®

3D, IMAX

^®

3D Dome, Experience It In IMAX

^®

,

The

IMAX

Experience


^®

,

An

IMAX

Experience


^®

,

An

IMAX

3D Experience


^®

, IMAX DMR

^®

, DMR

^®

, Filmed For IMAX

^™

, IMAX LIVE

^™

, IMAX Enhanced

^™

, IMAX nXos

^®

and Films to the Fullest

^®

, are trademarks and trade names of the Company or its subsidiaries that are registered or otherwise protected under laws of various jurisdictions. More information about the Company can be found at

www.imax.com

. You may also connect with IMAX on Instagram (


https://www.instagram.com/imax


), Facebook (

www.facebook.com/imax

), Twitter (

www.twitter.com/imax

) and YouTube (


www.youtube.com/imaxmovies


).

For additional information please contact:

Forward-Looking Statements

This earnings release contains forward looking statements that are based on IMAX management’s assumptions and existing information and involve certain risks and uncertainties which could cause actual results to differ materially from future results expressed or implied by such forward looking statements. These forward-looking statements include, but are not limited to, references to business and technology strategies and measures to implement strategies, competitive strengths, goals, expansion and growth of business, operations and technology, future capital expenditures (including the amount and nature thereof), industry prospects and consumer behavior, plans and references to the future success of IMAX Corporation together with its consolidated subsidiaries (the “Company”) and expectations regarding the Company’s future operating, financial and technological results. These forward-looking statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate in the circumstances. However, whether actual results and developments will conform with the expectations and predictions of the Company is subject to a number of risks and uncertainties, including, but not limited to, risks related to the adverse impact of the COVID-19 pandemic;


risks associated with investments and operations in foreign jurisdictions and any future international expansion, including those related to economic, political and regulatory policies of local governments and laws and policies of

the United States

and

Canada

, as well as geopolitical conflicts, such as the conflict between

Russia

and

Ukraine

; risks related to the Company’s growth and operations in

China

; the performance of IMAX DMR

^®

films; the signing of IMAX Theater System agreements; conditions, changes and developments in the commercial exhibition industry; risks related to currency fluctuations; the potential impact of increased competition in the markets within which the Company operates, including competitive actions by other companies; the failure to respond to change and advancements in digital technology; risks relating to consolidation among commercial exhibitors and studios; risks related to brand extensions and new business initiatives; conditions in the in-home and out-of-home entertainment industries; the opportunities (or lack thereof) that may be presented to and pursued by the Company; risks related to cyber-security and data privacy; risks related to the Company’s inability to protect the Company’s intellectual property;


risks related to climate change; risks related to weather conditions and natural disasters that may disrupt or harm the Company’s business; risks related to the Company’s indebtedness and compliance with its debt agreements; general economic, market or business conditions; risks related to political, economic and social instability, including with respect to the

Russia

–

Ukraine

conflict; the failure to convert IMAX Theater System backlog into revenue; changes in laws or regulations; any statements of belief and any statements of assumptions underlying any of the foregoing; other factors and risks outlined in our periodic filings with the SEC; and other factors, many of which are beyond the control of the Company. Consequently, all of the forward-looking statements made in this earnings release are qualified by these cautionary statements, and actual results or anticipated developments by the Company may not be realized, and even if substantially realized, may not have the expected consequences to, or effects on, the Company

.

These factors, other risks and uncertainties and financial details are discussed in IMAX’s most recent Annual Report on Form 10-K. The Company undertakes no obligation to update publicly or otherwise revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Primary Reporting Groups

The Company has the following reportable segments: (i) IMAX DMR; (ii) Joint Revenue Sharing Arrangements (“JRSA”); (iii) IMAX Systems; (iv) IMAX Maintenance; (v) Other Theater Business; (vi) Film Distribution; and (vii) Film Post-Production. The Company’s activities that do not met the criteria to be considered a reportable segment are disclosed within All Other. The Company organizes its reportable segments into the following three categories, identified by the nature of the product sold or service provided:

(i)            IMAX Technology Network, which earns revenue based on contingent box office receipts and includes the IMAX DMR segment and contingent rent from JRSA segment;

(ii)            IMAX Technology Sales and Maintenance, which includes results from the IMAX Systems, IMAX Maintenance and Other Theater Business segments, as well as fixed revenues from the JRSA segment; and

(iii)            Film Distribution and Post-Production, which includes activities related to the distribution of large-format documentary films, primarily to institutional theaters, and the distribution of exclusive experiences ranging from live performances to interactive events with leading artists and creators (through the Film Distribution segment) and the provision of film post-production and quality control services.

In the first quarter of 2022, the Company’s internal reporting was updated to reclassify the results of IMAX Enhanced, an initiative to bring The IMAX Experience® into the home, out of the New Business Initiatives segment and into All Other for segment reporting purposes. IMAX Enhanced™ was the only component of the New Business Initiatives segment. Prior period comparatives have been reclassified to conform with the current period presentation. Please refer to the Company’s Form 10-Q for the period ended

June 30, 2022

for additional segment information.

_______________

(1)     For the three months ended

June 30, 2022

, includes four IMAX Theater Systems that were relocated from their original locations (2021 — nil). When a theater system under a sales or sales-type lease arrangement is relocated, the amount of revenue earned by the Company may vary from transaction-to-transaction and is usually less than the amount earned for a new sale. In certain situations when a theater system is relocated, the original location is upgraded to an IMAX Laser Theater System.

(2)     Includes 43 IMAX Theater Systems where the customer has the option to convert from a joint revenue sharing arrangement to a sales arrangement (2021 — 44).

(3)     Includes 201 new IMAX Laser Theatre systems configurations and 111 upgrades of existing locations to IMAX Laser Theater Systems configurations.

(4)     Includes 155 new IMAX Laser Theatre systems configurations and 96 upgrades of existing locations to IMAX Laser Theater Systems configurations.

(5)     Period-to-period changes are reported net of the effect of permanently closed theaters.

_______________

(1)     The revenue from this segment principally includes after-market sales of IMAX Theater system parts and 3D glasses.

(2)     All Other includes the results from IMAX Enhanced and other ancillary activities. In the first quarter of 2022, the Company’s internal reporting was updated to reclassify the results of IMAX Enhanced out of the New Business Initiatives segment into All Other for segment reporting purposes. Prior period comparatives have been revised to conform with the current period presentation.

IMAX CORPORATION

NON-GAAP FINANCIAL MEASURES

(in thousands of U.S. dollars)

In this release, the Company presents adjusted net income (loss) attributable to common shareholders and adjusted net income (loss) attributable to common shareholders per basic and diluted share, EBITDA, Adjusted EBITDA per Credit Facility, Adjusted EBITDA margin, and free cash flow as supplemental measures of the Company’s performance, which are not recognized under U.S. GAAP. Adjusted net income (loss) attributable to common shareholders and adjusted net income (loss) attributable to common shareholders per basic and diluted share exclude, where applicable: (i) share-based compensation; (ii) COVID-19 government relief benefits (iii) legal judgment and arbitration awards; (iv) realized and unrealized investment gains or losses, as well as the related tax impact of these adjustments, and (v) income taxes resulting from management’s decision to no longer indefinitely reinvest the historical earnings of certain foreign subsidiaries.

The Company believes that these non-GAAP financial measures are important supplemental measures that allow management and users of the Company’s financial statements to view operating trends and analyze controllable operating performance on a comparable basis between periods without the after-tax impact of share-based compensation and certain unusual items included in net loss attributable to common shareholders. Although share-based compensation is an important aspect of the Company’s employee and executive compensation packages, it is a non-cash expense and is excluded from certain internal business performance measures.

A reconciliation of net loss attributable to common shareholders and the associated per share amounts to adjusted net income (loss) attributable to common shareholders and adjusted net income (loss) attributable to common shareholders per diluted share is presented in the table below. Net loss attributable to common shareholders and the associated per share amounts are the most directly comparable GAAP measures because they reflect the earnings relevant to the Company’s shareholders, rather than the earnings attributable to non-controlling interests.

In addition to the non-GAAP financial measures discussed above, management also uses “EBITDA,” as such term is defined in the Company’s Credit Agreement, and which is referred to herein as “Adjusted EBITDA per Credit Facility.” As allowed by the Credit Agreement, Adjusted EBITDA per Credit Facility includes adjustments in addition to the exclusion of interest, taxes, depreciation and amortization. Adjusted EBITDA per Credit Facility measure is presented to allow a more comprehensive analysis of the Company’s operating performance and to provide additional information with respect to the Company’s compliance against its Credit Agreement requirements when applicable. In addition, the Company believes that Adjusted EBITDA per Credit Facility presents relevant and useful information widely used by analysts, investors and other interested parties in the Company’s industry to evaluate, assess and benchmark the Company’s results.

EBITDA is defined as net income or loss excluding (i) income tax expense or benefit; (ii) interest expense, net of interest income; (iii) depreciation and amortization, including film asset amortization; and (iv) amortization of deferred financing costs. Adjusted EBITDA per Credit Facility is defined as EBITDA excluding: (i) share-based and other non-cash compensation; (ii) realized and unrealized investment gains or losses; (iii) write-downs, net of recoveries, including asset impairments and credit loss expense; and (iv) legal judgment and arbitration awards.

A reconciliation of net loss attributable to common shareholders, which is the most directly comparable GAAP measure, to EBITDA and Adjusted EBITDA per Credit Facility is presented in the table below. Net loss attributable to common shareholders is the most directly comparable GAAP measure because it reflects the earnings relevant to the Company’s shareholders, rather than the earnings attributable to non-controlling interests.

Free cash flow is defined as net cash provided by or used in operating activities minus cash used in investing activities (from the Condensed Consolidated Statements of Cash Flows). Management views free cash flow, a non-GAAP measure, as a measure of the Company’s after-tax cash flow available to reduce debt, add to cash balances, and fund other financing activities. Free cash flow does not represent residual cash flow available for discretionary expenditures. A reconciliation of cash provided by operating activities to free cash flow is presented below.

These non-GAAP measures may not be comparable to similarly titled amounts reported by other companies. Additionally, the non-GAAP financial measures used by the Company should not be considered as a substitute for, or superior to, the comparable GAAP amounts.

_______________

(1)     The Senior Secured Net Leverage Ratio is calculated using Adjusted EBITDA per Credit Facility determined on a trailing twelve-month basis.

(2)     The amortization of deferred financing costs is recorded within Interest Expense in the Condensed Consolidated Statement of Operations.

(3)

(4)        Weighted average ownership percentage for change in non-controlling interest share

_______________

(1)     Reflects amounts attributable to common shareholders.

View original content to download multimedia:

https://www.prnewswire.com/news-releases/imax-corporation-reports-second-quarter-2022-results-301595609.html

SOURCE IMAX Corporation